CommercialCoverageMedium impact
Upcoming Policies effective May 2, 2026
Blue Cross and Blue Shield of Minnesota·MN · Neurology, Oncology, Pain Management +4 more·Medical Policy
Effective date
May 4, 2026
We identified it
Jun 20, 2026
Summary
Blue Cross Minnesota revised policies for MRI-guided ultrasound ablation procedures, functional neuromuscular electrical stimulation devices, percutaneous facet joint denervation, and genetic testing for hereditary breast/ovarian cancer. The policy defines specific medical necessity criteria and documentation requirements for coverage determination.
Action Required
Before May 4, 2026: Billing team must review and update prior authorization workflows for MRI-guided ultrasound procedures, neuromuscular stimulation devices, facet joint denervation, and genetic testing. Update documentation checklists to ensure all medical necessity criteria are met before submitting claims. Train providers on new coverage criteria to prevent claim denials.